Literature DB >> 1623897

The influence of posture on the response to loop diuretics in patients with chronic cardiac failure is reduced by angiotensin converting enzyme inhibition.

A D Flapan1, E Davies, C Waugh, B C Williams, T R Shaw, C R Edwards.   

Abstract

The diuretic and natriuretic response to an intravenous dose of frusemide 40 mg was assessed in the erect and supine positions in 10 patients with cardiac failure who were being treated with enalapril 10 mg twice daily in addition to diuretics (Enalapril group) and in 10 patients with cardiac failure taking diuretics alone (Control group). Total 4 h diuresis in the erect position was 728 ml and in the supine position was 824 ml in the patients taking enalapril compared to 655 ml in the erect position and 1166 ml in the supine position in those patients taking diuretics alone. Total 4 h natriuresis in the erect positions was 78 mmol and in the supine position was 85 mmol in patients taking enalapril 10 mg twice daily but in those patients taking diuretics alone total 4 h natriuresis in the erect position was 67 mmol increasing to 120 mmol in the supine position. Measurements of plasma renin activity and plasma angiotensin II concentration confirmed effective converting enzyme inhibition, in the group of patients taking enalapril, but in those patients taking diuretics alone the erect position was associated with an increase in plasma renin activity, and plasma concentrations of angiotensin II and aldosterone. We conclude that the renin angiotensin system is a major factor in mediating the effect of posture on loop diuretic drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623897     DOI: 10.1007/bf00265919

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  Studies on the control of aldosterone secretion in man.

Authors:  V H James; R D Tunbridge; G A Wilson
Journal:  J Steroid Biochem       Date:  1976 Nov-Dec       Impact factor: 4.292

2.  Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.

Authors:  H Ring-Larsen; J H Henriksen; C Wilken; J Clausen; H Pals; N J Christensen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-24

3.  Furosemide effect on isolated perfused tubules.

Authors:  M Burg; L Stoner; J Cardinal; N Green
Journal:  Am J Physiol       Date:  1973-07

4.  Orthostatic changes of haemodynamics, renal function, plasma catecholamines and plasma renin concentration in normal and hypertensive man.

Authors:  M Molzahn; T Dissmann; S Halim; F W Lohmann; W Oelkers
Journal:  Clin Sci       Date:  1972-02       Impact factor: 6.124

5.  The development and application of a direct radioimmunoassay for plasma aldosterone using 125I-labeled ligand--comparison of three methods.

Authors:  E A Al-Dujaili; C R Edwards
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

6.  Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

Authors:  M A Creager; J L Halperin; D B Bernard; D P Faxon; C D Melidossian; H Gavras; T J Ryan
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

7.  Comparison of captopril and enalapril in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; M Yushak; N Medina
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

8.  Furosemide kinetics and dynamics in aged patients.

Authors:  A L Kerremans; Y Tan; H van Baars; C A van Ginneken; F W Gribnau
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

9.  Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.

Authors:  A Fujimura; A Ebihara
Journal:  Hypertension       Date:  1988-05       Impact factor: 10.190

10.  Effect of angiotensin II and captopril on renal tubular function in man.

Authors:  R Düsing; J Moritz; K Glänzer; H J Kramer
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

View more
  3 in total

1.  Fluid Management in Patients with Chronic Heart Failure.

Authors:  Pierpaolo Pellicori; Kuldeep Kaur; Andrew L Clark
Journal:  Card Fail Rev       Date:  2015-10

Review 2.  Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.

Authors:  John W Ostrominski; Muthiah Vaduganathan
Journal:  Clin Cardiol       Date:  2022-06       Impact factor: 3.287

Review 3.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.